| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.23 | 0.0002 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 0.0004 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |